Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Market Cap	1.96B -33.6%
Revenue (ttm)	5.41B -13.7%
Net Income	-3.93B
EPS	-3.52
Shares Out	1.12B
PE Ratio	n/a
Forward PE	12.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,018,100
Open	1.720
Previous Close	1.750
Day's Range	1.280 - 1.720
52-Week Range	0.990 - 6.000
Beta	1.02
Analysts	Sell
Price Target	2.48 (+87.88%)
Earnings Date	May 14, 2026

About BVMF:ONCO3

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, chemotherapy, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stoma...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Country: Brazil
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ONCO3

Financial Performance

In 2025, BVMF:ONCO3's revenue was 5.74 billion, a decrease of -7.83% compared to the previous year's 6.23 billion. Losses were -3.62 billion, 460.8% more than in 2024.